Anticancer therapy with angiogenesis inhibitors

Tumori. 2001 Nov-Dec;87(6):S14-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Angiogenesis Inhibitors / therapeutic use
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Clinical Trials as Topic
  • Endothelial Growth Factors / antagonists & inhibitors
  • Humans
  • Lymphokines / antagonists & inhibitors
  • Metalloendopeptidases / antagonists & inhibitors
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neovascularization, Pathologic / drug therapy*
  • Neovascularization, Pathologic / prevention & control*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Receptors, Growth Factor / antagonists & inhibitors
  • Receptors, Vascular Endothelial Growth Factor
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Endothelial Growth Factors
  • Lymphokines
  • Receptors, Growth Factor
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Receptor Protein-Tyrosine Kinases
  • Receptors, Vascular Endothelial Growth Factor
  • Metalloendopeptidases